sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Mon May 25
A 21-year-old cofounder’s sales pitch to clients begs them to question the company’s results: ‘Do not trust us. Do not trust our model’
1w
Y
Is Eversource Energy Stock Underperforming the Nasdaq?
1w
Y
Dear Nebius Stock Fans, Mark Your Calendars for June 22
1w
Y
Leveraged loan issuers increase amend-and-extend deals to take out credit facilities
1w
Y
Bank of America takes firm position on inflation, economy
1w
Y
Sandisk Stock Is the Most Overbought Stock in History
1w
Y
Why Broadcom Stock Is Bouncing Higher Today
1w
Y
TotalEnergies: Saudi Refinery Won’t Fully Recover Until 2027
1w
Y
LGBTQ consumers cut spending at Target, Walmart, Amazon over DEI
1w
Y
Is This The Best Time to Buy Broadcom (AVGO)?
1w
Y
Is ASML (ASML) The Best Undervalued AI Stock?
1w
Y
Bitcoin Whale Pays Price For Borrowing Binge As Buying Power Flags
1w
Y
The Great Gilt Gamble: U.K. Bonds Tank as Labour Civil War Heats Up
1w
Y
Stocks Mixed Ahead of FOMC Meeting Results
1w
Y
Is Corpay Stock Outperforming the S&P 500?
1w
Y
Worried About a Market Crash? These 3 Dividend Stocks Could Help Reduce Your Risk
1w
Y
Top High-Yield Dividend Stocks to Buy With $1,000 Right Now
1w
Y
Why Jabil's Stock Jumped 14% Wednesday Morning
1w
Y
How Is Interactive Brokers' Stock Performance Compared to Other Capital Markets Stocks?
1w
Y
Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant’s Upcoming Depression Data
1w
Y
How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer Bet
1w
Y
How Allogene Therapeutics (ALLO) Is Expanding Its Off-the-Shelf CAR T Platform Across Cancer and Autoimmune Disease
1w
Y
Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel’s Accelerated Approval Path
1w
Y
How Cabaletta Bio (CABA) Is Turning Rese-cel Enrollment and New Financing Into a Clearer Autoimmune Cell Therapy Setup
1w
Y
Why Autolus Therapeutics (AUTL) Looks Less Speculative as AUCATZYL Revenue Builds
1w
Y
Can You Guess What Income Makes You Rich? Hint — Even $450K A Year Doesn't Make The Cut For A Family Of 4
1w
Y
SpaceX’s Historic Post-IPO Rally Loses Steam as Retail Frenzy Cools
1w
Y
Stantec Stock Just Hit a 52-Week Low — But Analysts Say It’s a Buy
1w
Y
Why Citi Keeps Pounding the Table on Texas Instruments Stock
1w
Y
Why Jabil Stock Is One of the S&P 500’s Biggest Gainers
1w
Y
Should You Buy Bitcoin While It's Under $69,000?
1w
Y
Pizza Hut is being sold for $2.7 billion, as the iconic brand struggles to compete against delivery apps.
1w
Y
🔎 Under the Radar: CarMax Stock Slides as CEO Flags Challenges
1w
Y
Prediction: Sandisk Stock Will Soar to $5,000 in 2 Years
1w
Y
Flywire vs. Visa: Which Financial Payments Stock Is a Better Buy in 2026?
1w
Y
For Warsh's Balance Sheet Plans, Look to Bowman and Bessent
1w
Y
SpaceX stock slips for first time, poised to end 3-day surge
1w
Y
Americans’ 401(k) balances hit record levels last year. See how you compare.
1w
Y
How Is NRG Energy's Stock Performance Compared to Other Utility Stocks
1w
Y
Former Ripple CTO Draws a Sharp Line Between Investing and Gambling
1w
Y
What is Amazon’s free cash flow in 2026?
1w
Y
Morningstar Wealth to Launch Public/Private Model Portfolios
1w
Y
SoFi Just Helped Everyday Investors Buy Into the Largest IPO Ever. Here's Why It Matters More Than One Hot Deal.
1w
Y
Jim Cramer Discusses Alphabet Inc. (GOOGL)’s AI Chips
1w
Y
How To Earn $500 A Month From KB Home Stock Ahead Of Q2 Earnings
1w
Y
What Time Is the Fed Rate Decision Today? Plus, How to Watch Warsh's Press Conference.
1w
Y
Jim Cramer Shares Unmissable Insights About Broadcom (AVGO)
1w
Y
Jim Cramer Wonders Whether Nvidia Corp (NVDA)’s Becoming Like Apple
1w
Y
Here’s Why Jim Cramer Thinks CoreWeave Inc. (CRWV)’s The Best
1w
Y
AI Agents Are Changing Cybersecurity Forever. Zscaler Is Positioning Itself to Win Big.
1w
Y
More →